SOJO UNIVERSITY
Research Achievements Database
Japanese
Search Page
>
FACULTY OF PHARMACEUTICAL SCIENCES Department of Pharmaceutical Sciences
> Takechi Shinji
(Last updated : 2023-01-23 09:44:57)
Takechi Shinji
Department / Course
FACULTY OF PHARMACEUTICAL SCIENCES Department of Pharmaceutical Sciences
Job
Achievement
Book and thesis
Academic conference presentation
Business career
Present specialized field
Book and thesis
1.
2022/09
Papers
Dihydropyrazine suppresses TLR4-dependent inflammatory responses by blocking MAPK signaling in human hepatoma HepG2 cells The Journal of Toxicological Sciences,pp.381-387 (Co-authored)
2.
2022/02
Papers
Use of a baculovirus-mammalian cell expression-system for expression of drug-metabolizing enzymes: optimization of infection with a focus on cytochrome P450 3A Frontiers in Pharmacology 13 (Co-authored)
3.
2020/10
Papers
The carboxyl-terminal di-lysine motif is essential for catalytic activity of UDP-glucuronosyltransferase 1A9. Drug metabolism and pharmacokinetics 35 (5),pp.466-474 (Co-authored)
4.
2020/07
Papers
The effect of dihydropyrazines on lipopolysaccharide-stimulated human hepatoma HepG2 cells via regulating the TLR4-MyD88-mediated NF-κB signaling pathway. The Journal of Toxicological Sciences 45 (7),pp.401-409 (Co-authored)
5.
2019/10
Papers
β-Naphthoflavone , an exogenous ligand of aryl hydrocarbon receptor , disrupts zinc homeostasis in human hepatoma HepG2 cells. The Journal of Toxicological Sciences 44 (10),pp.711-720 (Co-authored)
Display All(44)
Academic conference presentation
1.
2010/12
Identification of a Dihydropyrazine-Glutathione Adduct (Biochemistry and Molecular Biology 2010 (BMB2010))
2.
2011/07
Development synthesis of dihydropyrazines having DNA strand-breakage activity (The 17th European Symposium on Organic Chemistry)
3.
2017/09
New familial amyotrophic lateral sclerosis with benign progression and myoclonus in lower extremities (The XXIII World Congress of Neurology)
4.
2017/09
Long-term observation of benign familial amyotrophic lateral sclerosis (FALS) with a H46R mutation in superoxide dismutase1 gene (SOD1) (The XXIII World Congress of Neurology)
Business career
1.
2012/04/01 ~
/(DC)Division of Pharmaceutical Sciences
2.
2012/04/01 ~
Graduate School of Engineering /Division of Applied Chemistry
3.
2011/04/01 ~
SOJO UNIVERSITY FACULTY OF PHARMACEUTICAL SCIENCES Department of Pharmaceutical Sciences
4.
2007/04/01 ~ 2011/03/31
SOJO UNIVERSITY FACULTY OF PHARMACEUTICAL SCIENCES Department of Pharmaceutical Sciences
5.
2005/04/01 ~ 2007/03/31
SOJO UNIVERSITY FACULTY OF PHARMACEUTICAL SCIENCES Department of Pharmaceutical Sciences
Present specialized field
Molecular biology, Others, Pharmaceutical hygiene and biochemistry, Hygiene and public health: including laboratory approach